Further limitations that stem from mTOR may serve as a novel molecular target to optimize individual therapy; we need further researches to be conducted to identify the precise signaling pathway of mTOR involved in the pathogenesis of ESCC. Here, MTOR is linked to esophageal squamous cell carcinoma.